Our team at Research & Development is aimed to develop a comprehensive product portfolio of generic Peptides which are used in several chronic therapy areas such as cancer, diabetes, cardiovascular, hypertension, and Osteoporosis for the Indian as well as the regulatory market. The analytical development facility is capable to analyse the generic as well as novel peptides under one roof.
With updated cutting age technology and high ended instruments at current set up Peptides up to 40 natural and /or unnatural amino acid sequence can be synthesis, purify and qualified to use development batches for further study up to scale of 50-100 gm final output.